You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
31 August 2026 - US pharmaceutical company Eli Lilly and Company (NYSE: LLY) on Monday announced that it has agreed to acquire Merida Biosciences, Inc., a biotechnology business developing precision biologics for autoimmune and allergic diseases.The ...
31 August 2026 - Formosa Pharmaceuticals, Inc. (TWSE: 6838), a Taiwan-based biopharmaceutical company, announced on Friday that it has submitted a Clinical Trial Application (CTA) to European regulatory authorities to conduct a pivotal clinical trial...
31 August 2026 - Ascletis Pharma Inc. (Ascletis) (HKEX: 1672), a fully integrated biotechnology company, announced on Sunday that it has dosed its first participant in a global Phase III clinical programme of ASC30 for chronic weight management.ASC30...
28 August 2026 - Medical technology company GE HealthCare (Nasdaq:GEHC) on Friday unveiled three additions to its Vivid cardiovascular ultrasound portfolio: Vivid Explorer, Vivid Advanced and Vivid Focus, designed to address imaging and workflow need...
28 August 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) said on Friday that new analyses from the multinational MILOS study demonstrate the real-world impact of bempedoic acid, used alone or in combination with ezetimibe, in man...
28 August 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) and German biotechnology company BioNTech SE (NASDAQ:BNTX) announced on Thursday that the US Food and Drug Administration (FDA) has approved their 2026-2027 COVID-19 vaccine formula ...
28 August 2026 - Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company based in Sydney, Australia, announced on Thursday new data showing that its lead asset, paxalisib, achieved a 100% clinical benefit rate in six ev...